Blood Systems Inc

“Significant changes to blood systems, inc. (the "corporation") bylaws effective august 23, 2013: 1. The maximum number of trustees who may serve on the board of trustees was changed from seventeen to nineteen. Significant changes to blood systems, inc. (the "corporation") bylaws effective november 22, 2013: 1. The minimum number of trustees who may serve on the board of trustees was changed from seven to nine. 2. The provision concerning election of trustees was amended to state that, so long as the corporation is its sole member, belle bonfils memorial blood center has the authority to designate two individuals to the board of trustees. A provision was also added stating so long as the corporation is the sole member of blood centers of the pacific, inland northwest blood centers, or belle bonfils memorial blood center, any amendment to the bylaws affecting such entities' rights to designate individuals to the board of trustees requires the consent of the applicable entity. 3. The provision concerning the filling of vacancies on the board of trustees was amended to state that, so long as the corporation is the sole member of blood centers of the pacific, inland northwest blood centers, or belle bonfils memorial blood center, respectively, if a vacant office was held by a trustee designated by such entity, that only the applicable entity may fill the vacancy, and that any amendment to such provision requires the consent of the applicable entity.”

“The form 990 is reviewed by management, including confirmation of compensation disclosures against w-2 and 1099 reporting. A copy of the draft form 990 and all schedules is supplied to all board members prior to the meeting held to accept the returns. The w-2s and 1099s are available for board review upon request. The paid preparer, ernst & young, and members of management review the form 990 with the committees and are available for answering questions. Any comments from the board are considered prior to filing with the irs.”

“The board of trustees has a compensation and human resource committee whose purpose, among other things, is to hire an independent consulting firm once every 2-3 years to provide data on competitiveness of salaries and benefits for the ceo and other officers of the corporation. The human resource department collects information through surveys and other sources in addition to the independent consulting firm. The members of the human resource and compensation committee of the board are all independent trustees and include no members of management. The recommendations of the committee are reviewed by the entire board prior to approval. Compensation for these individuals is set and approved by the board each year. The results of these discussions, reviews and approvals are documented in the executive minutes of the board meetings. This process was last completed in 2011.”

“The board of trustees has a compensation and human resource committee whose purpose, among other things, is to hire an independent consulting firm once every 2-3 years to provide data on competitiveness of salaries and benefits for the ceo and other officers of the corporation. The human resource department collects information through surveys and other sources in addition to the independent consulting firm. The members of the human resource and compensation committee of the board are all independent trustees and include no members of management. The recommendations of the committee are reviewed by the entire board prior to approval. Compensation for these individuals is set and approved by the board each year. The results of these discussions, reviews and approvals are documented in the executive minutes of the board meetings. This process was last completed in 2011.”

“The form 990 is made available on the company's intra-net for all operating locations to access. Upon request, the form can be printed or viewed on-line. Upon written request to the chief financial officer, a copy of the form 990 will be mailed to the requestor. The form 990 for current and past years is also posted on guidestar for organizations to access. The governing documents and conflict of interest policy are not made available to the public. The organization's combined financial statements are made public via the annual report posted on the organization's website.”

“In the prior year, sally caglioti and eugene robertson were reported as an officer and key employee, respectively, of blood systems, inc. (bsi). Creative testing solutions (cts), a related 501(c)(3) organization, leased their employees from bsi in 2012, including sally caglioti and eugene robertson. In 2013 cts hired their own employees, including sally caglioti and eugene robertson. Thus, they are no longer considered an officer or key employee of bsi. For this reason, they are being reported as former.”

“The mission of blood systems, inc. ("bsi") is to make a difference in people's lives by bringing together the best people, inspiring individuals to donate blood, producing a safe and ample blood supply, advancing cutting-edge research and embracing continuous quality improvement. To further its mission, bsi operates 18 community blood centers. These centers recruit blood donors and collect, process and distribute approximately 1,300,000 blood donations to meet the blood needs of patients in more than 500 hospitals throughout the country. The staff of nearly 2,900 serves a geographic area covering one-third of the united states, from the gulf coast to california and from the canadian border to mexico. Bsi is known more commonly throughout the united states by the name of its blood banking division, united blood services. Bsi is licensed by the u.s. Food and drug administration ( "fda" ) as a provider of blood and blood services. The company's three operating divisions are: (1) the blood banking division, which includes united blood services; (2) the biocare division; and (3) the blood systems research institute. These operating divisions are unincorporated divisions doing business under registered tradenames and service marks. Bsi conducts its blood banking activities through its regional blood centers located in the following states: alabama, arizona, arkansas, california, colorado, louisiana, mississippi, montana, nevada, new mexico, north dakota, south dakota, texas and wyoming. The biocare division distributes plasma-derived products through hospitals, community blood center locations and also directly from its headquarters in tempe, arizona. Blood-related research is conducted at the blood systems research institute located in san francisco, california.”

“4a) united blood services - blood banking the blood banking division operates under the name united blood services (ubs). The primary purpose of ubs is to provide a safe and stable supply of blood and blood components to hospitals and medical facilities. The strength of ubs is that it operates as local blood centers that are part of the community and yet has access to a large networked organization with all the advantages and efficiencies that are realized through standardization and economies of scale. Ubs collects blood from volunteer donors, performs screening and testing on the donated blood, and processes the whole blood into blood components such as red cells, platelets and plasma. Blood and blood components are then stored and distributed to hospitals and other health care providers. 4b) biocare - biological the biocare division provides biological products, primarily human-plasma derived products, that serve as adjunct therapies in transfusion medicine and healthcare. Plasma derivatives are basically protein therapies provided from plasma left over from whole blood donations. Examples of such plasma derivatives include: intravenous immune globulins, coagulation factors, albumin and fibrin sealants. These products are used as therapies for immune system disorders, bleeding disorders and wound management. 4c) blood systems research institute blood systems research institute ("bsri") facilitates research primarily funded by extramural grants (nih and others). The research is in transfusion medicine epidemiology, health policy, virology, viral discovery, the immune reaction to transfusion and to transfusion-transmitted infectious agents, cell therapy and genetic epidemiology. Areas studied include implications of receiving components at different storage ages; mechanism of virus entry into cells; how transfusion transmitted viruses cause symptoms; the use of commercially available or locally-developed donor tests; the factors leading to chimerism, etc. Bsri supports training programs for specialists in transfusion medicine and the development of epidemiology research scientists. Bsri investigators publish more than 45 papers each year in the peer-reviewed scientific literature. The research facility is staffed with 5 investigators, 24 research associates, 14 staff scientists and various other positions as well as administrative support. 4d) other program services consist of laboratory services and other program activities.”

“Pension recapture other than net periodic benefit 38,328,603”